ALK and non-small cell lung carcinoma: The ALK fusion gene expression in the plasma of ALK fusion gene (+) NSCLC patients was 33.2 to 987.4 (mean 315.2), which was significantly higher than that of ALK fusion gene negative NSCLC patients [0.36 to 13.04 (mean 4.58)].